Geoinvesting Guest Post On Cliff Note #93

Minimum 100% Short-Term Upside In This Turnaround Med-Tech Company

On 8th of July, this medical device stock was the 93rd company we added to our MS Microcap Quality Index (MSMqi). On 19th of September , we co-hosted a Live Fireside chat with Geoinvesting, where had an in-depth discussion with the new CEO of this company to learn more about its turnaround story that finally reflected.

So, we thought it would be a good idea to share Geoinvesting’s full research report they just published on the company that ties the story together.

Enjoy :)

Highlights

• The company’s turnaround is driven by operational restructuring, a focus on higher-margin U.S. markets, and a patient-first approach, led by its new CEO.

• The company has reported two consecutive quarters of profitability, with strong revenue growth and flat operating expenses.

• We expect a near-term upside of at least 100%.

• Key catalysts include continued sales and EPS growth, as well as the divestiture of the medical coatings business.

• The CEO says the company is taking market share “like crazy in the vascular access and wound care spaces.”

• He adds, “We’ve built a model that scales well. We’ve bottomed out on operating expenses and are now poised to make investments that will fuel the next phase of growth, without eroding profitability.”